AMRN:NASDAQ
Amarin Corporation PLC
$13.63
arrow_downward
-1.73%(-0.24) 1D
Sep 18, 4:00:02 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for AMRN...
Open
$13.84
High
$13.90
Low
$13.58
Mkt. cap
287.90M
Avg. vol.
70.29K
Volume
50.66K
52-wk high
$20.90
52-wk low
$13.12
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
Open
$13.84
High
$13.90
Low
$13.58
Mkt. cap
287.90M
Avg. vol.
70.29K
Volume
50.66K
52-wk high
$20.90
52-wk low
$13.12
EPS
-$1.30
Beta
0.76
Shares outstanding
21.12M
No. of employees
80
News stories
From web sources and news partners
CarePlus VietNam
·
1 month ago
AMRN Q2 2026 Earnings: EPS Blows Past Estimates by 492%, Shares Slip - EPS Revision Trend
CarePlus VietNam
·
1 month ago
AMRN Q2 2026 Earnings: Strong Earnings Beat Amidst Operational Progress - Earnings Acceleration Picks
CarePlus VietNam
·
1 month ago
AMRN Q1 2026 Earnings: Significant EPS Miss Amid Ongoing Operational Challenges - Earnings Surprise Stocks
Profile
Amarin Corporation is an Irish-American biopharmaceutical company founded in 1993 and headquartered in Dublin, Ireland and Bridgewater, New Jersey. The company develops and markets medicines for the treatment of cardiovascular disease. It has developed the drug Vascepa, a prescription grade omega-3 fatty acid.
In July 2012, their lead-candidate drug named Vascepa received FDA-approval, competing against GlaxoSmithKline's Lovaza. Wikipedia
About Amarin Corporation PLC
CEO-
Employees80
FoundedMar 1, 1989
HeadquartersDublin, Leinster, Ireland
SectorBiotechnology
Websiteamarincorp.com